2014
DOI: 10.1371/journal.pone.0105828
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: The development of modular constructs that include antigenic regions targeted by protective immune responses is an attractive approach for subunit vaccine development. However, a main concern of using these vaccine platforms is how to preserve the antigenic identity of conformational B cell epitopes. In the present study we evaluated naturally acquired antibody responses to a chimeric protein engineered to contain a previously defined immunodominant domain of the Plasmodium vivax reticulocyte binding protein-1… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
24
0

Year Published

2015
2015
2019
2019

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 16 publications
(26 citation statements)
references
References 52 publications
2
24
0
Order By: Relevance
“…A possible caveat when using chimeric recombinant proteins is the potential expression of neoantigens when the structure of the natural protein is modified. Naturally acquired antibodies in a population with differences in exposure and immunity (31) were able to recognize PvRMC-CSP when tested by ELISAs, confirming that the antigenic domains of CSP are conserved in our construct. The recognition of P. vivax sporozoites by mice immunized with PvRMC-CSP further confirms that antibody responses induced by this vaccine candidate are directed toward the P. vivax CSP native sequences.…”
Section: Discussionsupporting
confidence: 67%
See 2 more Smart Citations
“…A possible caveat when using chimeric recombinant proteins is the potential expression of neoantigens when the structure of the natural protein is modified. Naturally acquired antibodies in a population with differences in exposure and immunity (31) were able to recognize PvRMC-CSP when tested by ELISAs, confirming that the antigenic domains of CSP are conserved in our construct. The recognition of P. vivax sporozoites by mice immunized with PvRMC-CSP further confirms that antibody responses induced by this vaccine candidate are directed toward the P. vivax CSP native sequences.…”
Section: Discussionsupporting
confidence: 67%
“…To evaluate reactivity of naturally acquired antibodies against PvRMC-CSP, plasma samples were selected from 251 individuals from communities in Rondonia, a state in the western Amazon region of Brazil, where malaria is endemic. In the last 5 years, P. vivax malaria accounted for more than 70% of all malaria cases in the region as reported (30,31). The majority of the studied population consists of rainforest natives who have resided in the region where malaria is endemic for more than 25 years or transmigrants from several areas of Brazil where malaria is not endemic who have lived in Rondonia for 10 years or more.…”
Section: Methodsmentioning
confidence: 85%
See 1 more Smart Citation
“…While malaria infection represents a key selection pressure for the human leukocyte antigen (HLA), and has left clear evolutionary footprints on the alleles observed in different countries [17], the association between HLA gene expression and responsiveness (or non-responsiveness) to defined malaria antigens has produced contradictory results [1821]. Beyond the extreme genetic diversity of HLA class II, which hinders interpretation of the role of HLA on antibody responses elicited during malaria, most studies rely on antibody prevalence data collected at a single time-point in cross-sectional analysis of a population.…”
Section: Introductionmentioning
confidence: 99%
“…However, other studies did not find associations between HLA-DR or HLA-DQ alleles and antibody response to P. vivax antigens. In a study performed by Ferreira and co-workers, no genetic restriction mediated by HLA-DRB1* and HLA-DQB1* against two constructions of P. vivax Reticulocyte Binding Protein-1 (PvRBP1) was verified in more than 500 HLA alleles from different individuals from communities in the Amazon region of Brazil ( 86 ). Moreover, regarding the cellular response, Arevalo-Herrera et al also did not observe association between HLA and cellular immune response of healthy volunteers vaccinated with CSP derived long synthetic peptides ( 96 ) and Lima-junior et al describe five promiscuous peptides from MSP-9 which also presented no association between HLA-DRB1 alleles and the cellular immune response ( 97 ).…”
Section: Hla Class I and Ii Genes And P Vivax Antmentioning
confidence: 99%